Evidence map›Paper›PMID 34853826›Full record

ArticleHemaSphere2021

The EHA Research Roadmap: Normal Hematopoiesis.

Thierry Jaffredo, Alessandra Balduini, Anna Bigas, Rosa Bernardi, Dominique Bonnet, Bruno Canque, Pierre Charbord, Anna Cumano, Ruud Delwel, Charles Durand and 31 more

Abstract readEditorial
In one paragraph

Article in HemaSphere, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

41 authors.

Thierry JaffredoSorbonne Université, Institut de Biologie Paris Seine, Laboratoire de Biologie du Développement/UMR7622, Paris, France.
Alessandra BalduiniDepartment of Molecular Medicine, University of Pavia, Italy.
Anna BigasHospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.
Rosa BernardiIRCCS San Raffaele Scientific Institute, Milan, Italy.
Dominique BonnetThe Francis Crick Institute, London, United Kingdom.
Bruno CanqueINSERM U976, Universite de Paris, Ecole Pratique des Hautes Etudes/PSL Research University, Institut de Recherche Saint Louis, France.
Pierre CharbordSorbonne Université, Institut de Biologie Paris Seine, Laboratoire de Biologie du Développement/UMR7622, Paris, France.
Anna CumanoUnité Lymphopoïèse, Département d'Immunologie, INSERM U1223, Institut Pasteur, Cellule Pasteur, Université de Paris, France.
Ruud DelwelDepartment of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Charles DurandSorbonne Université, Institut de Biologie Paris Seine, Laboratoire de Biologie du Développement/UMR7622, Paris, France.
Willem FibbeLeiden University Medical Center, The Netherlands.
Lesley ForresterCentre for Regenerative Medicine, Institute for Regeneration and Repair, University of Edinburgh, Scotland.
Lucia de FranceschiUniversità degli Studi di Verona, Italy.
Cedric GhevaertUniversity of Cambridge, United Kingdom.
Bjørn GjertsenDepartment of Medicine, Hematology Section, Haukeland University Hospital, Bergen, Norway.
Berthold GottgensWellcome - MRC Cambridge Stem Cell Institute and Department of Haematology, University of Cambridge, United Kingdom.
Thomas GrafCenter for Genomic Regulation, Barcelona Institute for Science and Technology and Universitat Pompeu Fabra, Barcelona, Spain.
Olaf HeidenreichPrinses Máxima Centrum voor kinderoncologie, Utecht, The Netherlands.
Olivier HermineDepartment of Hematology and Laboratory of Physiopathology and Treatment of Blood Disorders, Hôpital Necker, Imagine institute, University of Paris, France.
Douglas HiggsMRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, United Kingdom.
Marina KleanthousThe Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.
Hannes KlumpInstitute for Transfusion Medicine, University Hospital Essen, Germany.
Valerie KouskoffUniversity of Manchester, United Kingdom.
Daniela KrauseGoethe University Frankfurt and Georg-Speyer-Haus, Frankfurt am Main, Germany.
George LacaudCancer Research UK Manchester Institute, The University of Manchester, United Kingdom.
Cristina Lo CelsoImperial College London, United Kingdom.
Joost H A MartensDepartment of Molecular Biology, RIMLS, Radboud University, Nijmegen, The Netherlands.
Simón Méndez-FerrerUniversity of Cambridge and NHSBT, Cambridge, United Kingdom.
Pablo MenendezCentro de Investigación Biomedica en Red-Oncología (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.
Robert OostendorpDepartment of Internal Medicine III, Technical University of Munich, School of Medicine, Germany.
Sjaak PhilipsenDepartment of Cell Biology, Erasmus University Medical Center Rotterdam, The Netherlands.
Bo PorseThe Finsen Laboratory, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, Denmark.
Marc RaaijmakersDepartment of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Catherine RobinHubrecht Institute-KNAW and University Medical Center Utrecht, The Netherlands.
Henk StunnenbergPrinses Máxima Centrum voor kinderoncologie, Utecht, The Netherlands.
Kim Theilgaard-MönchThe Finsen Laboratory, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, Denmark.
Ivo TouwDepartment of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands.
William VainchenkerGustave Roussy, Villejuif, France.
Joan-Lluis Vives CorronsRed Blood Cell and Hematopoietic Disorders Research Unit, Institute for Leukaemia Research Josep Carreras, Badalona, Barcelona.
Laurent YvernogeauSorbonne Université, Institut de Biologie Paris Seine, Laboratoire de Biologie du Développement/UMR7622, Paris, France.
Jan Jacob SchuringaDepartment of Experimental Hematology, University Medical Center Groningen, The Netherlands.

Funding

Cancer Research UK 26670Cancer Research UK 26770Medical Research Council MC_PC_17230Medical Research Council MR/T000384/1Medical Research Council MR/T013923/1Medical Research Council MR/V005421/1
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34853826
PMCPMC8615310

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.